Shanghai Allist Pharmaceuticals Co. Ltd. A (688578) — Financial Flexibility Index
Shanghai Allist Pharmaceuticals Co. Ltd. A (688578) has a Financial Flexibility Index of 0.97x as of September 2025. Free cash flow of CN¥734.52 Million (operating CF CN¥670.83 Million minus capex CN¥63.68 Million) represents 1% of total liabilities (CN¥760.53 Million). Check 688578 cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Shanghai Allist Pharmaceuticals Co. Ltd. A Financial Flexibility Index (2017–2024)
Historical Financial Flexibility Index trend for Shanghai Allist Pharmaceuticals Co. Ltd. A across 8 annual periods. For the full cash flow conversion analysis, see 688578 cash generation efficiency.
Annual Financial Flexibility Index for Shanghai Allist Pharmaceuticals Co. Ltd. A (2017–2024)
Year-by-year free cash flow to debt coverage for Shanghai Allist Pharmaceuticals Co. Ltd. A. Explore 688578 cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | 2.90x | CN¥1.84 Billion | CN¥1.57 Billion | CN¥633.32 Million | ▲ +53.9% |
| 2023 | 1.88x | CN¥742.53 Million | CN¥674.65 Million | CN¥394.22 Million | ▲ +104.1% |
| 2022 | 0.92x | CN¥235.46 Million | CN¥91.63 Million | CN¥255.12 Million | ▼ -34.6% |
| 2021 | 1.41x | CN¥221.54 Million | CN¥29.29 Million | CN¥156.99 Million | ▲ +242.0% |
| 2020 | -0.99x | CN¥-108.29 Million | CN¥-196.75 Million | CN¥109.01 Million | ▲ +15.8% |
| 2019 | -1.18x | CN¥-170.01 Million | CN¥-259.37 Million | CN¥144.02 Million | ▼ -485.6% |
| 2018 | -0.20x | CN¥-61.27 Million | CN¥-97.25 Million | CN¥303.96 Million | ▼ -323.1% |
| 2017 | 0.09x | CN¥11.51 Million | CN¥10.11 Million | CN¥127.37 Million | — |